☆ 4.7 Article

Development of ARPE-19-Equipped Ocular Cell Model for In Vitro Investigation on Ophthalmic Formulations

PHARMACEUTICS (2023)

Related references

Note: Only part of the references are listed.

Editorial Material Agriculture, Dairy & Animal Science

3Rs Principle and Legislative Decrees to Achieve High Standard of Animal Research

Paolo Verderio et al.

Summary: The 3Rs principle, consisting of Replacement, Reduction and Refinement, aims to promote ethical and scientifically valid animal experimentation. It requires the consideration of alternative models, statistical designs, and improvements in experimental conditions. The principle was first introduced in a document by the Council Directive in 1986 and developed further in the European Parliament and Council Directive in 2010. This article emphasizes the importance of the 3Rs principle, particularly the concept of Reduction, and highlights the need for its consistent implementation among countries and research teams.

ANIMALS (2023)

Add to Collection

Article Pharmacology & Pharmacy

Ex Vivo Visualization of Distribution of Intravitreal Injections in the Porcine Vitreous and Hydrogels Simulating the Vitreous

Tobias Auel et al.

Summary: The behavior of intravitreal dosage forms in vivo is usually studied through animal experiments during preclinical development. However, the use of in vitro vitreous substitutes (VS) for preclinical investigations has not been sufficiently explored. This study compared the distribution of a contrast agent in hyaluronic acid agar gels and polyacrylamide gels with that in ex vivo porcine vitreous using magnetic resonance imaging. The results showed that while both gels could not completely represent the porcine vitreous body, the distribution in the polyacrylamide gel was similar. On the other hand, the distribution in the hyaluronic acid agar gel was much faster. Anatomical features such as the lens and interfacial tension could also affect the distribution, making it difficult to reproduce using in vitro VS.

PHARMACEUTICS (2023)

Add to Collection

Review Instruments & Instrumentation

In vitro dissolution testing models of ocular implants for posterior segment drug delivery

Muhammad Faris Adrianto et al.

Summary: Drug delivery to the posterior segment of the eye is challenging, with intraocular implants offering long-term therapy but facing challenges in selecting appropriate in vitro dissolution testing models. While in vitro test models can analyze drug release profiles, they may not accurately predict in vivo drug exposure.

DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2022)

Add to Collection

Article Pharmacology & Pharmacy

The EyeFlowCell: Development of a 3D-Printed Dissolution Test Setup for Intravitreal Dosage Forms

Tobias Auel et al.

Summary: The study developed an in vitro dissolution model called EyeFlowCell (EFC) to test intravitreal dosage forms, showing that drug release from implants in the gel-based EFC may better predict drug release rates compared to compendial release methods.

PHARMACEUTICS (2021)

Add to Collection

Article Pharmacology & Pharmacy

Investigating Ex Vivo Animal Models to Test the Performance of Intravitreal Liposomal Drug Delivery Systems

Gustav Christensen et al.

Summary: This study demonstrated the feasibility of using fresh porcine eyes as a model for testing intravitreal biodistribution and retention of liposomes, providing insights into important considerations for ocular drug delivery. The results showed that PEG-coated liposomes were rapidly absorbed on the retina, while positively charged and PEG-coated liposomes were retained for at least 24 hours. Toxicity experiments on murine-derived retinal explant cultures indicated increased photoreceptor cell death at higher concentrations of anionic and cationic liposomes.

PHARMACEUTICS (2021)

Add to Collection

Review Pharmacology & Pharmacy

Role of In Vitro Models for Development of Ophthalmic Delivery Systems

Shallu Kutlehria et al.

Summary: There is a growing need for physiologically accurate in vitro models for ophthalmic drug screening and disease modeling. Various types of in vitro models have been developed, each with its own advantages and disadvantages. Technological advancements and integration with tissue engineering have provided novel platforms that better mimic the in vivo microenvironment, showing potential for transforming ophthalmic drug development.

CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS (2021)

Add to Collection

Review Medicine, Research & Experimental

Methodological aspects and pharmacological applications of three-dimensional cancer cell cultures and organoids

Federica Foglietta et al.

LIFE SCIENCES (2020)

Add to Collection

Article Chemistry, Multidisciplinary

Thermosensitive Nanocomposite Hydrogels for Intravitreal Delivery of Cefuroxime

Simona Sapino et al.

NANOMATERIALS (2019)

Add to Collection

Article Engineering, Biomedical

Wet-AMD on a Chip: Modeling Outer Blood-Retinal Barrier In Vitro

Minhwan Chung et al.

ADVANCED HEALTHCARE MATERIALS (2018)

Add to Collection

Review Materials Science, Biomaterials

In Vitro Modeling of Tumor-Immune System Interaction

Chantal Mengus et al.

ACS BIOMATERIALS SCIENCE & ENGINEERING (2018)

Add to Collection

Review Materials Science, Biomaterials

In Vitro Modeling of Tumor-Immune System Interaction

Chantal Mengus et al.

ACS BIOMATERIALS SCIENCE & ENGINEERING (2018)

Add to Collection

Article Pharmacology & Pharmacy

Influence of the test method on in vitro drug release from intravitreal model implants containing dexamethasone or fluorescein sodium in poly (D,L-lactide-co-glycolide) or polycaprolactone

Sandra Stein et al.

EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2018)

Add to Collection

Article Ophthalmology

Effects of ranibizumab (Lucentis (R)) and bevacizumab (Avastin (R)) on human corneal endothelial cells

Patrick R. Merz et al.

BMC OPHTHALMOLOGY (2018)

Add to Collection

Article Ophthalmology

Bevacizumab clearance through the iridocorneal angle following intravitreal injection in a rat model

Orly Gal-Or et al.

EXPERIMENTAL EYE RESEARCH (2016)

Add to Collection

Article Engineering, Biomedical

Bioreactor-engineered cancer tissue-like structures mimic phenotypes, gene expression profiles and drug resistance patterns observed in vivo

Christian Hirt et al.

BIOMATERIALS (2015)

Add to Collection

Article Chemistry, Medicinal

The PK-Eye: A Novel In Vitro Ocular Flow Model for Use in Preclinical Drug Development

Sahar Awwad et al.

JOURNAL OF PHARMACEUTICAL SCIENCES (2015)

Add to Collection

Article Ophthalmology

Pharmacokinetics of bevacizumab after topical and intravitreal administration in human eyes

Elad Moisseiev et al.

GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2014)

Add to Collection

Article Chemistry, Medicinal

Simulation of Drug Distribution in the Vitreous Body After Local Drug Application into Intact Vitreous Body and in Progress of Posterior Vitreous Detachment

Christian Loch et al.

JOURNAL OF PHARMACEUTICAL SCIENCES (2014)

Add to Collection

Article Ophthalmology

Pharmacokinetics of Intravitreally Injected Bevacizumab in Vitrectomized Eyes

Jeeyun Ahn et al.

JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2013)

Add to Collection

Article Ophthalmology

ANATOMIC AND PHARMACOKINETIC PROPERTIES OF INTRAVITREAL BEVACIZUMAB AND RANIBIZUMAB AFTER VITRECTOMY AND LENSECTOMY

John B. Christoforidis et al.

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2013)

Add to Collection

Review Cell & Tissue Engineering

Three-Dimensional Scaffolds for Tissue Engineering Applications: Role of Porosity and Pore Size

Qiu Li Loh et al.

TISSUE ENGINEERING PART B-REVIEWS (2013)

Add to Collection

Article Chemistry, Medicinal

Flow-Through Cell Apparatus (USP Apparatus 4): Operation and Features

Nikoletta Fotaki

DISSOLUTION TECHNOLOGIES (2011)

Add to Collection

Article Ophthalmology

Pharmacokinetics of intravitreal bevacizumab (Avastin (R)) in rabbits

Christos I. Sinapis et al.

CLINICAL OPHTHALMOLOGY (2011)

Add to Collection

Article Ophthalmology

Pharmacokinetics of Bevacizumab after Topical, Subconjunctival, and Intravitreal Administration in Rabbits

Hiroyuki Nomoto et al.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2009)

Add to Collection

Article Ophthalmology

Effects of bevacizumab (Avastin) on retinal cells in organotypic culture

Stefanie Kaempf et al.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2008)

Add to Collection

Article Ophthalmology

RAGE ligand upregulation of VEGF secretion in ARPE-19 cells

Wanchao Ma et al.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2007)

Add to Collection

Article Engineering, Biomedical

Experimental investigation of vitreous humour motion within a human eye model

R Repetto et al.

PHYSICS IN MEDICINE AND BIOLOGY (2005)

Add to Collection

Review Biotechnology & Applied Microbiology

Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer

N Ferrara et al.

NATURE REVIEWS DRUG DISCOVERY (2004)

Add to Collection

Article Chemistry, Medicinal

A pharmacokinetic model for ocular drug delivery

K Tojo

CHEMICAL & PHARMACEUTICAL BULLETIN (2004)

Add to Collection

Article Pharmacology & Pharmacy

Reconstruction of an in vitro cornea and its use for drug permeation studies from different formulations containing pilocarpine hydrochloride

S Tegtmeyer et al.

EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2001)

Add to Collection

© Peeref 2019-2024. All rights reserved.